Unknown

Dataset Information

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.


ABSTRACT:

Background

Novel drug regimens are needed for tuberculosis (TB) treatment. New regimens aim to improve on characteristics such as duration, efficacy, and safety profile, but no single regimen is likely to be ideal in all respects. By linking these regimen characteristics to a novel regimen's ability to reduce TB incidence and mortality, we sought to prioritize regimen characteristics from a population-level perspective.

Methods and findings

We developed a dynamic transmission model of multi-strain TB epidemics in hypothetical populations reflective of the epidemiological situations in India (primary analysis), South Africa, the Philippines, and Brazil. We modeled the introduction of various novel rifampicin-susceptible (RS) or rifampicin-resistant (RR) TB regimens that diffe

SUBMITTER: Kendall EA 

PROVIDER: S-EPMC5207633 | biostudies-literature | 2017 Jan

REPOSITORIES: biostudies-literature